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Abstract: Hypertension is one of the most prevalent diseases and is often called the “silent killer”
because there are usually no early symptoms. Hypertension is also associated with multiple
morbidities, including chronic kidney disease and cardiovascular disease. Early detection and
intervention are therefore important. The current routine method for diagnosing hypertension is
done using a sphygmomanometer, which can only provide intermittent blood pressure readings and
can be confounded by various factors, such as white coat hypertension, time of day, exercise, or stress.
Consequently, there is an increasing need for a non-invasive, cuff-less, and continuous blood pressure
monitoring device. Multi-site photoplethysmography (PPG) is a promising new technology that can
measure a range of features of the pulse, including the pulse transit time of the arterial pulse wave,
which can be used to continuously estimate arterial blood pressure. This is achieved by detecting
the pulse wave at one body site location and measuring the time it takes for it to reach a second,
distal location. The purpose of this review is to analyze the current research in multi-site PPG for
blood pressure assessment and provide recommendations to guide future research. In a systematic
search of the literature from January 2010 to January 2019, we found 13 papers that proposed novel
methods using various two-channel PPG systems and signal processing techniques to acquire blood
pressure using multi-site PPG that offered promising results. However, we also found a general lack
of validation in terms of sample size and diversity of populations.
J. Clin. Med. 2019, 8, 1827; doi:10.3390/jcm8111827 www.mdpi.com/journal/jcm
J. Clin. Med. 2019, 8, 1827 2 of 14
Keywords: photoplethysmography; digital health; global health; intensive care unit; anesthesia;
wearable devices; pulse arrival time; pulse transit time; pulse wave; pulse oximeter;
hypertension assessment
1. Introduction
Hypertension (HTN), defined as a blood pressure (BP) above 140/90 mmHg on two or more
occasions, is one of the most prevalent diseases, affecting over 1 billion people world-wide [1].
The European Society of Cardiology and the European Society of Hypertension estimates that by 2025,
the number of affected people will be 1.5 billion [1]. HTN is often called the “silent killer” because
there are usually no symptoms, but it is associated with chronic kidney disease, cardiovascular disease,
and death [2]. In addition, hypertension in pregnancy is associated with preterm birth, still birth,
intrauterine growth restrictions, neonatal thrombocytopenia, and bronchopulmonary dysplasia [3].
Therefore, early detection and intervention are critical.
1.1. The Need for a Non-Invasive Continuous Blood Pressure Monitor
The current industry gold standards of blood pressure assessment are the manual
sphygmomanometer (BP cuff) and invasive blood pressure (IBP) measurements [4]. The invasive
arterial line is currently only used in high-risk surgical patients or critically ill patients who require
instantaneous BP measurements [5]. As expected, it is not used outside of the inpatient setting
because of the risks associated with arterial cannulation, such as temporary occlusion, infection, or
vascular damage [5]. The cuff-based sphygmomanometer is the most frequently used method of BP
measurement in hospitals, in family practice offices, and at home. While the manual auscultatory
method is the gold standard, the automatic BP cuff is also often used because of its convenience.
The automatic BP cuff depends on the measurement of oscillometric changes in pressure during
cuff deflation [6]. However, in both BP cuff methods, BP can only be measured intermittently and
can be affected by factors such as white coat HTN, masked HTN, caffeine, exercise, or stress [7].
These measurements also provide no additional information on the cardiovascular status of the
patient. Intermittent measurements using a sphygmomanometer are therefore not an ideal method for
monitoring the long-term management of HTN [8]. Additionally, ambulatory home BP self-monitoring
has been shown to be able to detect HTN disorders earlier than office measurements [9]. There are
currently 24-h ambulatory BP monitoring (24hABPM) devices that can measure BP intermittently
over the span of a day that have been shown to improve accuracy and predict cardiovascular risk.
While the 24hABPM is superior to the BP cuff methods in that it can track BP trends throughout the
day, it is not entirely non-invasive. The patient has to carry the device with an attached cuff that is set
to inflate once every 15–20 min [10], which can be distracting and uncomfortable at the least, and could
even cause microvascular damage (bruising) and pain in some patients [11]. In addition, the use of
this device is costly [10]. As the prevalence of HTN increases, there is a growing need for a wearable,
cuff-less, and non-invasive BP monitor that is cost-effective and can continuously monitor a patient’s
blood pressure throughout day-to-day activities.
1.2. Photoplethysmography to Estimate BP
Photoplethysmography (PPG) is a technology that illuminates perfused tissue and then measures
light that is either reflected or transmitted back to a photosensor, giving a measurement of blood
volume [12]. Traditionally, PPG has been used to measure oxygen saturation in the finger, widely
known as the pulse oximetry technique; however, PPG has also been shown to be able to detect
changes in blood volume and the pulse wave of blood flow during systole [12]. The ability of PPG to
detect the arterial pulse wave is a promising method for obtaining continuous BP measurements in
a small and convenient wearable device. There have been increasing numbers of studies exploring
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this potential over the past decade, investigating using PPG in combination with electrocardiography
(ECG), ballistocardiography (BCG), phonocardiography (PCG), impedance plethysmography (IPG),
and tonometry [13]. Notably, many papers use a combination of ECG and PPG to estimate BP, with
ECG used to determine the start of systole and PPG used in the periphery to determine the time taken
for the pulse wave to reach a certain distance. This measured time is known as the pulse arrival time
(PAT), which is defined as the time it takes the pulse wave to travel from the heart to the periphery and
is proportional to BP [14].
1.3. Vagueness of Terminology
One of the difficulties of understanding research in PPG is the interchangeability of several key
terms. This inconsistency in terminology can create confusion between research questions, protocol
development, and findings, so we wanted to address it early in the review. In many publications, PAT
is used interchangeably with pulse transit time (PTT). These two are not the same; the key difference is
when this time interval starts. The beginning of the PAT is measured from the R wave of the ECG;
therefore, it includes the pre-ejection period (PEP), which is the time it takes for blood to leave the
heart after the heart’s electrical impulse [15]. PTT on the other hand is defined as the time it takes for
a pulse wave to travel a known distance and does not include the PEP. It is inversely proportional
to pulse wave velocity (PWV), which is the speed of the pulse wave along the arterial vessel [16].
Another point of confusion is that multi-site PPG is often used to describe a system that uses two PPG
probes, but it can extend up to multiple channels [17]. In this review, we will consider dual PPG (two
probes) as the key type of multi-site PPG in blood pressure assessment.
1.4. Multi-Site PPG
One of the limitations of the ECG–PPG method is that the PAT includes the PEP. This artifact
reduces the accuracy of the BP estimation [15]. One of the ways to account for this is to measure
the pulse wave at a proximal location rather than to measure the electrical impulse of the heart.
Several studies have examined multi-site dual PPG based on just two PPG sensors, in which the ECG
is replaced by a second PPG, thereby removing the confounding PEP component [16]. The resulting
time interval from when the pulse wave is detected by the first PPG to when it is detected by the
distal PPG is known as the pulse transit time (PTT), which is more accurately correlated to BP than
the PAT [15]. The two PPG probes can be relatively proximal–distal, that is, not directly connected
in the vascular tree (e.g., forehead to toe) [18], or they can be proximal–distal along the same artery
(e.g., proximal brachial to distal brachial artery), as shown in Figure 1 [16]. Figure 2 shows an example
of multi-site PPG being used to calculate PTT such that it is significantly correlated (p < 0.001) with
systolic BP (SBP). Note that each data point in Figure 2 represents a subject for either PTT (ear to toe)
or (finger to toe), where a total of 116 subjects were used in the analysis.
We performed a literature search for all research from January 2010 to January 2019 regarding
multi-site PPG as a method for BP measurement. The purpose of this review is to gain an understanding
of multi-site PPG as one of the potential technologies amongst several (Figure 1) to assess the current
trends in the literature and to guide future research. We found that the amount of research in this field
is limited. The majority of the studies on multi-site PPG had small sample sizes (e.g., typically 5–20
healthy subjects), with no hypertensive subjects or subjects with co-morbidities. Therefore, it appears
that there is a lack of validation for this technology in clinical groups.
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Figure 1. A visualization of the methods multi-site photoplethysmography (PPG) to measure the 
pulse transit time (PTT). Multisite PPG can make use of twos PPG probes, one proximal and one 
distal, to measure the time it takes for the pulse wave to travel a distance. (A,B) Two-location dual 
PPG/iPPG systems. (C) iPPG system. (D) Single artery dual PPG system. (E) Multiple wavelengths 
system. ECG—electrocardiography, IPG—impedance plethysmography, 
BCG—ballistocardiography, PCG—phonocardiography, PPG—photoplethysmography, 
iPPG—image-based PPG, and MWPPG—multi-wavelength PPG. 
 
Figure 2. Dual probe multi-site PPG-derived pulse transit time (PTT) correlation with systolic blood 
pressure (SBP). The data used in this figure were adapted from Allen and Murray [19]. 
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2. Methods
We conducted a thorough lite ature search using PubMed fo articles exploring the use of multi-site
PPG for BP measuremen from 1/1/2010 to 1/1/2019. PubMed was used because it gave access
journal articles as well as conference p ocee ings. W decided to limit our search to the most recent
dec de, i.e., January 2010 to January 2019, because we were i terested in the tren of the development
of this te hnology in the recent decadal time frame. Note that the typical time frame is the mo t
recent d cade [20–22]. We us d the foll wing search terms, combined with “OR”, using PubMed’s
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advanced search feature: ppg blood pressure determination, ppg blood pressure estimation, ppg
hypertension estimation, ppg non-invasive blood pressure, ppg cuffless blood pressure, ppg cuff-less
blood pressure, photoplethysmographic blood pressure determination, photoplethysmographic blood
pressure estimation, photoplethysmographic hypertension determination, photoplethysmographic
hypertension estimation, non-invasive hypertension classification, non invasive blood pressure
monitoring, pulse transit time blood pressure estimation, multi-ppg blood pressure, multi-site ppg
blood pressure, and multi-photoplethysmographic blood pressure. Our initial searches returned a
significant number of studies regarding arterial stiffness and vascular disease; we therefore added
the search term “NOT arterial stiffness.” We are aware of the relatedness of vascular disease with
hypertension [23]; however, including analysis of vascular disease via PPG would mean including
many studies unrelated to BP. Therefore, we decided to limit the scope of our study to multi-site PPG for
the analysis of BP in the hope that we could make more meaningful and BP focused recommendations.
We included any publication that examined multi-site PPG as a method for BP measurement.
Our exclusion criteria included animal studies, review articles, articles that are not accessible in the
English language (see the Appendix A), articles in which PPG was not used to estimate blood pressure,
and articles that validated a trademarked PPG device with no discussion of the PPG technology or
waveform itself. From January 2010 to January 2019, our search found 13 papers that fit the inclusion
criteria (Figure 3).
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3. Results
Our PubMed search found 13 publications that studied multi-site PPG technology; all but one
paper looked at using two measurement sites with a two-probe system [24]. The two probes are used
to measure PTT (or its inverse PWV), which is correlated with BP. From January 2010 to January 2019,
multi-site PPG publications followed a growing trend (Figure 4). In our analysis, we determined the
sample sizes of each paper, the inclusion of any subjects with HTN or co-morbidities, and the method
used as the gold standard to collect the reference BP measurements for comparison. Of these papers,
only three had a sample size of more than 30 subjects: one each in 2011 [18], 2017 [16], and 2018 [25].
In addition, most of the papers either used healthy subjects with no HTN, co-morbidities, or pregnant
women, or used health statuses that were undisclosed. One paper [26] compared hypertensive (N = 10)
and normotensive (N = 10) subjects, as well as patients undergoing coronary angiography (N = 4).
Another publication collected data from patients undergoing general anesthesia (N = 35) [18].
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3.1. Gold Standards
Several of the papers did not use the gold standard BP measurement methods (inter-arterial
line or sphygmomanometer) for their comparisons. Instead, they used less validated methods for
obtaining the reference BP, such as devices that employ the volume-clamp method, other PPG methods,
applanation tonometry, or no reported reference at all. The volume-clamp method, also known as
finger arterial non-invasive BP, uses a PPG probe to measure the volume of blood in the fingertip
and a beat-to-beat adjusting cuff that exerts pressure to maintain the volume detected by the PPG.
In theory, this cuff pressure is equal to the systolic BP. Some publications have verified its validity in
different applications [27], but others have shown its measurements to be different from invasive BP
measurements [28]. Since the automatic sphygmomanometer is widely used in the clinical setting,
for our study, we considered an automatic BP cuff as an appropriate gold standard [6]. Only eight
publications used an appropriate gold standard for assessing the reference BP, where two used invasive
arterial blood pressure and six used a sphygmomanometer (manual or automatic) (Figure 5)
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3.2. I duced Changes in BP
Many studies included a protocol that induced changes in BP during measurement, as shown
in Figure 6. In addition to physical exercise, other experimental tasks were used to drive changes
in the autonomic nervous system and thus alter BP as a response through the baroreceptors and
vasoconstriction. Such techniques included anesthesia, the Valsalva maneuver, a tilt table, and
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cold-pressor test. In other techniques, a brachial cuff was used to occlude the brachial artery, which
causes a rise in blood pressure in the carotid artery where the measurements take place [29]. Using these
techniques to induce changes in the blood pressure allowed the studies to show that the technology
is sensitive and accurate over some range of BPs. However, the range of induced BP values is
generally limited.
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Figure 6. A representation of the methods used in the studies to provoke changes in blood pres ure
during validation of the multi-si e PPG technique. Ex rcise = stationary calf aises, hand grip exercise,
or phy ical activity immediately before measurem nt; anesthesia = general anesth sia; cuff-induced
hypertension = BP cuff used to occlude the bra hial art ry to artificially raise the BP in the carotid;
Valsalva maneuver = exhaling against a closed glottis; N/R = no reported.
3.3. Accuracy of BP Estimation
The accuracy of BP estimations of each analyzed publication is summarized in Table 1. There were
two methods used to determine the accuracy in comparison with the reference BP: mean absolute
difference and Pearson’s correlation coefficient (r). Three publications did not analyze their method in
comparison to a reference BP. One publication expressed reliability in their measurements by showing
that beat-to-beat variations of the measured PWV was less than 15% [29]. Another analyzed the
correlation of PTT measurements from the wrist to different fingers (index, middle, ring, little) and
found an absolute correlation value of 0.95 [30]. The third publication compared the PTT using their
proposed method with PTT using the ECG–PPG method giving r value of 0.86 ± 0.06 [31]. Only one
study found that PTT was poorly correlated with BP [32].
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Table 1. Summary of findings of all papers included in this review.
Year Authors # Subjects
Age Range of
Subjects (Years) Gold Standard Parameters Measured
Mean BP
Absolute
Difference
Absolute of Value of
Correlation Coefficient between
Estimated BP (or PTT Feature)
and Referenced BP
2018 Liu et al. [26]
N1 = 10
N2 = 10
N/R Finometer PTT (ECG, ICG, FingerPPG)
PTT (MW FingerPPG)
1.86 mmHg MAP N/R
N3 = 4 N/R IBP 2.72 mmHg MAP N/R
2018 Wang et al. [25] N1 = 30 20–27 BP Cuff PTT (WristPPG to ArmPPG with MA) N/R
r = 0.75 SBP
r = 0.78 DBP
2018 Viejo et al. [24] N1 = 15 20–38 BP Cuff PTT (2 cheeksPPG, foreheadPPG) N/R r = 0.85 BP
2017 Nabeel et al. [16] N1 = 35 23–32 BP Cuff
PTT (CarotidPPG to CarotidPPG)
PTT (CarotidPPG to FingerPPG)
PTT (ECG to CarotidPPG)
N/R
r = 0.74 SBP
r = 0.77 DBP
r = 0.78 MAP
2017 Nabeel et al. [29] N1 = 5 24–30 Tonometry PTT (CarotidPPG to CarotidPPG) N/R N/R
2017 Beckmann et al.[30] N1 = 5 25–36 N/R
PTT (WristPPG to Index FingerPPG)
PTT (WristPPG to Middle FingerPPG)
PTT (WristPPG to Ring FingerPPG)
PTT (WristPPG to Little FingerPPG)
N/R N/R
2017 Zhang et al. [33] N1 = 29 20–30 BP Cuff
PTT (FacePPG to FingerPPG)
PTT (TemplePPG to WristPPG)
N/R r > 0.6 SBP in 75.9% subjects
2016 Nabeel et al. [34] N1 = 17 21–34 BP Cuff PTT (CarotidPPG to CarotidPPG) N/R
r = 0.68 SBP
r = 0.71 DBP
r = 0.72 MAP
2016 Liu et al. [35] N1 = 10 22–26 Finometer
PTT (ECG to FingerPPG)
PTT (MW FingerPPG)
N/R r = 0.76 SBP
2015 Nabeel et al. [36] N1 = 13 22–31 BP Cuff PTT (CarotidPPG to CarotidPPG) N/R
r = 0.5 SBP
r = 0.66 SBP
r = 0.63 MAP
2015 Liu et al. [31] N1 = 12 24–35 ECG–PPG PAT PTT (TemplePPG to Index FingerPPG) N/R N/R
2011 Chen et al. [18] N4 = 35 17–21 and 58–62 IBP PTT (EarPPG to ToePPG)
2.16 mmHg SBP
1.49 mmHg DBP N/R
2010 Proenca et al. [32] N1 = 20 20–37 Finometer
PTT (ECG, ICG, unspecified PPG)
PTT (EarPPG to FingerPPG)
N/R r = 0.22 SBP
N1 = normotensive subjects, N2 = hypertensive subjects, N3 = patients undergoing coronary angiography, N4 = patients under general anesthesia, r = Pearson’s correlation coefficient,
Finometer = finger blood pressure, IBP = invasive BP, MW = multi-wavelength, MA = motion artifact, ECG = electrocardiogram, ICG = impedance cardiography, PTT = pulse transit time,
N/R = not reported, SBP = systolic BP, DBP = diastolic BP, MAP = mean arterial pressure, FingerPPG = PPG collected from a finger.
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4. Discussion
Of the 13 publications, only one study, Chen et al. [32], found two-channel PTT (earlobe and finger,
N = 20) to be poorly correlated with BP. This poor correlation is suggested to be due to the fact that the
devices used had a low accuracy and sensitivity in comparison to the small changes in PTT associated
with the changes in BP. In their study, the PTT varied with a massive uncertainty of ±11 ms, which was
associated with a variation in the BP readings of approximately ±20 mmHg (r = 0.22).
One of the studies, Beckmann et al. [30], only looked at the reproducibility of the measurements
using a wrist to finger PPG (N = 5). This study had neither a gold standard for measuring the reference
blood pressure, nor did they have any reports of accuracy of their measurements. However, they were
able to show an excellent agreement within multiple measurements using different fingers (r = 0.95).
Another study, Viejo et al. [24] used multi-site PPG with more than two locations, using raw video
analysis of multiple locations of the face (N = 15). Using machine learning, they were able to create an
algorithm to predict the SBP with an accuracy of r = 0.85, which is the most accurate SBP prediction
amongst the studies included here.
Yet another study, Chen et al. [18], used ear–toe dual PPG to measure PWV to estimate BP.
The advantage of this study is that it was conducted on patients undergoing general anesthesia.
In addition, this is the only study included in our analysis that examined patients of different age
ranges (17–21 and 58–62 years). However, a limitation of their experiment is the small sample size.
Although they had more than 30 subjects (N = 35), they separated their experimental validation into
two separate experiments: validation of PWV (N = 9) and validation of BP measurement (N = 26).
Furthermore, they had two different age groups; therefore, it would be ideal to have a larger sample
size. Another limitation of the study is that there is insufficient information about the subjects. Chen et
al. notes that data acquisition was done in the operating room before, during, and after anesthesia.
However, how the nature of the surgeries, health of the subjects, and the use of any medication could
affect the BP is unknown.
4.1. Wearable PPG-Based Devices
One of the main motivators for studying multi-site PPG is its potential for incorporation into a
wearable device to continuously monitor BP in an ambulatory setting. This would be designed to
allow for the early detection of HTN and provide an accurate and complete profile of BP control in
hypertensive patients. Based on the research found, there seem to be two major barriers to creating a
wearable device. First, the device must be compact enough to be convenient to wear on a daily basis,
and second, PPG measurements are usually highly sensitive to body movements, where the signal
collected contains motion artifacts that can decrease the accuracy of the BP estimation.
4.2. Compact Design
A second study, Liu et al. [31], proposed the use of the front and back cameras on a smartphone to
measure PTT. The device used in the study had one camera surrounded by a ring of light-emitting
diode (LED) lights on one side and a standalone camera on the other side. The side with the LED lights
was pressed against the temple while the index finger of the right hand was pressed against the second
camera, in a position similar to when one is talking on a phone. The camera for the index finger was
illuminated using ambient light from both daylight and fluorescent lighting. One of the limitations
of this study was that they only compared this multi-site PTT result with an ECG–PPG-derived PTT.
They did not compare the PTT with any measurements of BP.
One of the earliest published multi-site PPG studies, McCombie et al. [37], demonstrated how
multiple PPG probes can be attached to a single artery on the hand in the form of an extended glove.
Although the PTT delay is quite short, the current microcontroller technology can readily measure
pulse timings with a microsecond accuracy and thus can be used to estimate BP changes.
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Similarly, Nabeel et al. [16,29,34,36], explored ways to collect multi-site PPG using only one probe
on one part of the body. They used a single device with one infrared (IR) LED and two PPG probes that
were a fixed distance apart to measure the PTT along a single artery. This solves several issues. First, it
eliminates the inaccuracies from estimating the distance between the two PPG probes. Second, when
two probes are located on different body parts, there is an inaccuracy associated with the multiple
branch points between points A and B and the multiple reflections of the wave. Lastly, only one device
is needed. Three of the four studies used a sphygmomanometer as the gold standard, while one used
tonometry [29]. Of the four studies, only one had a sample size of 35 normotensive subjects [16].
Another two studies, Liu et al. [26,35], explored the use of a single PPG device with
multi-wavelength probes for measuring PTT. Signals with shorter wavelengths were dispersed
superficially and represented capillaries, while longer wavelengths penetrated deeper and represented
arterioles. The time difference between IR-PPG (“arterioles”) and blue-PPG (“capillaries”) was used
to calculate PTT. This PTT was then compared with the ECG–PPG PTT. The BP was simultaneously
compared with a reference BP. The benefit of this method is that it allows for a small device that can be
worn in a single location; one of these studies suggested implementation into a smart watch, ring, or
earbud [26]. In addition, this study had four subjects that were undergoing a coronary angiography.
A limitation of these studies was that they used the finger clamp method as the gold standard.
4.3. Imaging PPG
More recently, it has been demonstrated that the optical pulse perfusion in the human skin can
be measured with a camera [38]. This technique is now known as “imaging PPG” (iPPG) or “video
plethysmography.” By processing the separate color channels in the camera image, the separate color
channels can be combined using blind source separation methods to reconstruct the pulse waveform.
Since a camera can measure the pulse at multiple points on the body simultaneously, researchers have
developed a variety of methods using iPPG to estimate blood pressure.
Hybrid techniques have also been developed. Zhang et al. [33] proposed a possible smart watch
application using contact PPG and iPPG. The smart watch would contain a contact PPG probe for
the wrist and a camera to analyze the face for an iPPG when the watch is raised towards head level.
The iPPG would then use computer software to analyze the changes in light on the skin surface to
detect the pulse wave. However, the iPPG was collected under a single fluorescent lamp only, and the
contact PPG used in the experiment was a normal finger PPG. It is unclear how the system would
perform under the varying spectrum of possible lighting scenarios in day-to-day living. Still, this study
provides a proof of concept for a nonintrusive method of obtaining two PPG signals to calculate BP.
The iPPG was first demonstrated on a smart phone by Poh et al. [39]. Fletcher et al. was one of the first
to investigate the effect of different ambient lighting on iPPG using an Android phone [40]. A recent
iPPG study [41], with the use of a smartphone camera, showed promising results toward measuring
blood pressure; however, the data were collected only from normotensive subjects.
4.4. Mitigating Motion Artifacts
Only one study, Wang et al. [25], addressed the issue of motion artifacts, a key challenge to reliable
clinical measurements with the PPG. Their study used two PPG sensors (one on the arm, one on the
wrist) and an accelerometer at the wrist. The accelerometer was used to identify and remove motion
artifacts from the PPG signal. The study was able to show reliable BP measurements while subjects
were walking with a normal arm swing. While this study was performed under controlled laboratory
settings that did not fully encompass the range of movement in day-to-day living, it did show that
motion artifacts can often be accounted for and its effects mitigated via signal processing, but that this
is a key area of development needed for ambulatory PPG-based BP assessments.
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5. Recommendations
As mentioned in the introduction, a vast majority of the publications use the term “multi-site PPG”
to describe a dual PPG system. In our literature search, there was only one study that used more than
two PPGs in the analysis of BP. This study used PPG analysis of three facial regions in combination
with machine learning in order to develop an algorithm for BP prediction [24]. In addition, PTT and
PAT are routinely used interchangeably. Our recommendation is:
(1) to apply all recommendations in Elgendi [12] but in multiple PPG configurations,
(2) to compare the performance features extracted from signal PPG signals and multiple PPG
signals for assessing BP,
(3) to optimize the locations of measurement for extracting PTT that are correlated with BP,
(4) to include more unhealthy subjects with co-morbidities,
(5) to include subjects from different age ranges,
(6) to explore different noisy environments, and
(7) to investigate the integration of multiple PPG sensors (contact and non-contact) in intelligent
clothing or wearable devices.
A thorough literature search using PubMed revealed only 13 publications from January 2010 to
January 2019 regarding the use of multi-site PPG for BP estimation. The research suggests that PPG
simultaneously from a range of body sites is a promising approach for the continuous tracking of BP.
The current research landscape is lacking given the increasing need for a technology to continuously
and non-invasively monitor BP. The main shortcoming is that a majority of research studies do not
have large enough sample sizes, nor do they include participants with co-morbidities. That being said,
a surprising number of studies used a method of BP provocation, showing that their approaches are
sensitive to changes in BP. There were also many different approaches to creating a device that would
be convenient to wear on a daily basis. The direction of future research should be toward validating
the proposed technologies using larger sample sizes and broader populations.
6. Conclusions
A systematic review of multi-site PPG-based blood pressure measurement studies from January
2010 to January 2019 was conducted, revealing that there were many studies with promising PPG
technologies, but were not mature enough to make a powerful and statistically significant contribution
toward the reliable non-invasive measurement of arterial blood pressure. This review creates the
necessary motivation for research groups around the globe to intensify their efforts toward the
creation of a much needed disruptive technology offering non-invasive, cuff-less, continuous, and
calibration-free measurement of blood pressure.
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Appendix A Appendix
The titles (translated into English) of articles that are not accessible in English language:
(Clinical effect of lower tidal volume combined with lung recruitment maneuver on ARDS for
post-operative esophageal carcinoma surgery patients).
(Comparison of early retinal microvascular changes and microalbuminuria as indicators for
increased cardiovascular risk).
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(Pilot study: Wrist digital sphygmomanometers as an alternative for non-invasive blood pressure
measurement in pediatric population).
(Ventilation strategies for chronic obstructive pulmonary disease).
(Results of using the dosing Valsalva–Weber test to determine autonomic disorders in patients
with vasovagal syncope).
(Monitoring oxygen consumption in energy metabolism in pediatric anesthesia: clinical utility).
(Pulmonary hypertension: a rare cause of unexplained dyspnea).
(Minimally invasive treatment of Dupuytren’s contracture using Pi needle percutaneous
multi-segmental fasciotomy).
(Analysis of thyroid homeostasis disorders in patients with severe traumatic brain injury).
(Central sleep apnea (Ondine’s curse syndrome) in medullary infarction).
(The coronary patient six months after cardiac rehabilitation: rehabilitation evaluation research
(RER study)).
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